XML 22 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities:    
Net loss $ (4,831,240) $ (1,959,837)
Adjustments to reconcile net loss to net cash used in operating activities:    
Accretion of discount on marketable securities, net (338,208) 0
Stock-based compensation expense 796,796 133,492
Changes in fair value of convertible debt (0) 646,000
Changes in operating assets and liabilities:    
Prepaid expenses, deposits and other assets (1,028,399) (1,590,537)
Deferred offering costs 0 (1,059,768)
Accounts payable 63,383 483,556
Accrued expenses and other liabilities (604,556) 26,077
Grant receivable 915,404 0
Deferred grant revenue 1,401,501 1,169,222
Net cash used in operating activities (3,625,319) (3,443,795)
Cash flows from investing activities:    
Purchase of marketable securities (40,570,256) 0
Net cash used in investing activities (40,570,256) 0
Cash flows from financing activities:    
Proceeds from the sale of common stock, prefunded warrants and common stock warrants, net of offering costs 46,411,946 0
Net cash provided by financing activities 46,411,946 0
Net decrease in cash and cash equivalents 2,216,371 (3,443,795)
Cash and cash equivalents at beginning of period 7,792,846 4,093,579
Cash and cash equivalents at end of period 10,009,217 649,784
Supplemental disclosure of non-cash investing and financing activities:    
Unrealized loss on marketable securities 19,702 0
Stock options granted in lieu of cash bonus 255,724 0
Deferred offering costs in accounts payable 13,385 0
Cashless exercise of prefunded warrants $ 496 $ 0